Patient Guide: Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 194 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06074588
Status: 🟢 Enrolling Now
Condition: Non-small Cell Lung Cancer (NSCLC)
Phase: PHASE3

Find a Study Location Near You

This study is available at 194 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Los Angeles, California
  • • Jacksonville, Florida
  • • Orange City, Florida
  • • And 191 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Join Clinical Trial NCTNCT06074588

How to Join This Clinical Trial - NCTNCT06074588

Learn how to participate in this PHASE3 trial studying an investigational therapy for Non-small Cell Lung Cancer (NSCLC). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-small Cell Lung Cancer (NSCLC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-small Cell Lung Cancer (NSCLC)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06074588 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 194 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90404 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 32224 - United States

Status: RECRUITING

Clinical Research Site

Orange City, Florida 32763 - United States

Status: COMPLETED

Clinical Research Site

Marietta, Georgia 30060 - United States

Status: RECRUITING

Clinical Research Site

Detroit, Michigan 48201 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: RECRUITING

Clinical Research Site

Hattiesburg, Mississippi 39401 - United States

Status: RECRUITING

Clinical Research Site

Omaha, Nebraska 68198 - United States

Status: RECRUITING

Clinical Research Site

Englewood, New Jersey 07631 - United States

Status: RECRUITING

Clinical Research Site

Morristown, New Jersey 07960 - United States

Status: RECRUITING

And 184 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Non-small Cell Lung Cancer (NSCLC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation